| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/26/2006 | US20060019884 Peptide composition |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060018984 Intravaginal washing agent |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018849 Cosmetic or dermatological preparations of the oil-in-water type |
| 01/26/2006 | US20060018847 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 01/26/2006 | DE202005009813U1 Pharmaceutical composition, for treating skin diseases e.g. psoriasis, neurodermatitis and acne, comprises juniper tar (pix juniperi), carrier (e.g. Vaseline), perfume oil and oil |
| 01/26/2006 | CA2581155A1 Treatment of burns |
| 01/26/2006 | CA2581068A1 Treatment of tumours |
| 01/26/2006 | CA2574548A1 Use of hmgb1 for wound healing |
| 01/26/2006 | CA2573718A1 Hair growth promoting agents |
| 01/26/2006 | CA2568753A1 Use of a pharmaceutical composition comprising calcitriol and clobetasol propionate for the treatment of psoriasis |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1618885A1 Cosmetic and/or pharmaceutical compositions containing fatty acids and extracts of castanea sativa |
| 01/25/2006 | EP1617845A2 Compositions and methods for induction of opioid receptors |
| 01/25/2006 | EP1617830A2 Esterified fatty acid composition |
| 01/25/2006 | EP1513826B1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | CN1726217A Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/25/2006 | CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726199A Novel 2,4-diamino-1,3,5-triazine derivative |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726017A Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1726007A Extracts of decaffeinated coffee beans and orally administrable compositions comprised thereof for stimulating the sebaceous function of the skin |
| 01/25/2006 | CN1724521A New quinazoline hind derivative, medicinal composition containing same and their use |
| 01/25/2006 | CN1724079A Biologic external application medicine for curing wound |
| 01/25/2006 | CN1724058A Disinfectant liquid for treating hand/foot tinea |
| 01/25/2006 | CN1724057A Medicine for treating skin ulcer, burns and scald, and its prepn. method |
| 01/25/2006 | CN1724055A Medicinal composition for treating traumatic surface |
| 01/25/2006 | CN1724041A Liquid medicine for treating face skin disease |
| 01/25/2006 | CN1724039A External use liquid medicine |
| 01/25/2006 | CN1724020A Novel liquid for treating burns |
| 01/25/2006 | CN1724012A Traditional Chinese medicine contg. three kinds of herb medicines, and its prepn. method |
| 01/25/2006 | CN1723963A Health-care food with spot-removing function |
| 01/25/2006 | CN1723952A External use traditional Chinese medicinal preparation for treating ringworm of the nails |
| 01/25/2006 | CN1723941A Gynecologic antipruritic capsule, an dits prepn. method |
| 01/25/2006 | CN1723937A Plaster contg. tuber of hyacinth bletilla for treating burns |
| 01/25/2006 | CN1723931A Cure-all ointment for treating burns and scald |
| 01/25/2006 | CN1723930A Ointment for treating burns and scald, and its prepn. method |
| 01/25/2006 | CN1723929A Compounding liniment contg. traditional Chinese medicine and Western medicine for treating hoary hair |
| 01/25/2006 | CN1723916A Quick-acting decoction for treating burns and scald |
| 01/25/2006 | CN1723914A Compound medicine contg. heparin zinc, and its application |
| 01/25/2006 | CN1723910A Injectable azithromycin freeze-dried powder, and its prepn. method |
| 01/25/2006 | CN1723905A Cefdinir oral disintegration tablet, and its prepn. method |
| 01/25/2006 | CN1723881A Compounding medicine contg. coenzyme O30 for treating dermatosis, and its prepn. method |
| 01/25/2006 | CN1238391C Anion association polyurethane and use thereof as thickener |
| 01/25/2006 | CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 01/25/2006 | CN1238330C Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 01/25/2006 | CN1238032C Tincture for curing acne and preparation method |
| 01/25/2006 | CN1238019C Oil for comforting channels and collaterals |
| 01/25/2006 | CN1238005C Spot removing and face nursing capsule |
| 01/25/2006 | CN1237979C Use of phaeodactylum algae extract to promote proteasome activity of skin cells |
| 01/25/2006 | CN1237967C External use of indomethacin for treating cutaneous pruritus |
| 01/25/2006 | CN1237883C Collagen-DNA-Ag composition with bacteriostatic function and preparation thereof |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | CA2186193C Cosmetic compositions containing tricholine citrate |
| 01/24/2006 | CA2186042C Cosmetic or dermopharmaceutical patch containing in an anhydrous polymeric matrice at least one active component, especially unstable in oxidative media, and at least one water absorbing agent |
| 01/24/2006 | CA2100228C Phospholipid derivatives |
| 01/23/2006 | CA2512942A1 An improved method of treating inflammatory acne vulgaris and rosacea with carbamide peroxide |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006005844A1 Pressurized foaming composition for topical treatment of psoriasis |
| 01/19/2006 | WO2005117890A3 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014794 CXCR1 and CXCR2 chemokine antagonists |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014762 2-Pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014722 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060014709 Drug or cosmetic |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014282 Cell and tissue engineering utilizing LIF |
| 01/19/2006 | US20060014158 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 01/19/2006 | US20060013897 Compositions for cancer therapy saponins or sapogenins |
| 01/19/2006 | US20060013812 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 01/19/2006 | US20060013794 Cosmetic or pharmaceutical composition comprising peptides with the sequences arggly-ser |
| 01/19/2006 | DE102004027353A1 Use of tamsulosin hydrochloride for treating hemorrhoids and benign blood blisters in the anus |
| 01/19/2006 | CA2567742A1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 01/19/2006 | CA2567687A1 Pressurized foaming composition for topical treatment of psoriasis |
| 01/19/2006 | CA2567682A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |